Survival of grafts of genetically modified cardiac myocytes transfected with FITC-labeled oligodeoxynucleotides and the β-galactosidase gene in the noninfarcted area, but not the myocardial infarcted area

Authors:
  • RMR Morishita
    R Morishita
  • JHJ Higaki
    J Higaki
  • AMA Moriguchi
    A Moriguchi
  • SHS Hayashi
    S Hayashi
  • HMH Matsushita
    H Matsushita
  • IKI Kida
    I Kida
  • NTN Tomita
    N Tomita
  • YSY Sawa
    Y Sawa
  • YKY Kaneda
    Y Kaneda
  • TOT Ogihara
    T Ogihara
Publisher website
Google Scholar
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.